Plasma complement 3d levels in the early phase after pancreas transplantation

Annals of Transplantation

Volumn 14, Issue 3, 2009, Pages 29-35

  Suermann, Angela ^a   Vonend, Oliver ^b   Schenker, Peter ^a   Viebahn, Richard ^a   Rump, Lars C ^b   Weiner, Stefan M ^c  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

C3d; Pancreas graft rejection; Pancreas graft thrombosis; Predictive parameters; Simultaneous pancreas and kidney transplantation

Indexed keywords

COMPLEMENT COMPONENT C3D; DACLIZUMAB; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; AGED; ARTICLE; BLOOD; CASE REPORT; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT BLOOD LEVEL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG SUBSTITUTION; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY PANCREAS TRANSPLANTATION; KIDNEY TRANSPLANTATION; MALE; METABOLISM; MIDDLE AGED; PANCREAS GRAFT THROMBOSIS; PANCREAS TRANSPLANTATION; POSTOPERATIVE PERIOD; PREDICTION; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; RETRANSPLANTATION; RISK FACTOR; STEROID THERAPY; THROMBOSIS; TIME;

ADULT; AGED; COMPLEMENT ACTIVATION; COMPLEMENT C3D; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PANCREAS TRANSPLANTATION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; THROMBOSIS; TIME FACTORS; YOUNG ADULT;

EID: 70349146592     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Becker BN, Odorico JS, Becker YT et al: Simultaneous pancreas-kidney and pancreas trans-plantation. J Am Soc Nephro'l, 2001; 12: 2517-27
2. Smets YF, Westendorp RG, van der Pijl JW et al: Effect of simultaneous pancreas-kidney transplantation on mortality of patients with type-1 diabetes mellitus and end-stage renal failure. Lancet, 1999; 353: 1915-19
3. Gruessner AC, Sutherland DE: Pancreas transplant outcomes for United States (US) and non-US cases as reported to die United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004. Clin Transplant, 2005; 19: 433-55
4. Wullstein C, Woeste G, Taheri AS et al: [Morbidity following simultaneous pancreas/kidney transplantation ]. Chirurg, 2003; 74: 652-56
5. Lederer SR, Friedrich N, Regenbogen C et al: Non-invasive monitoring of renal transplant recipients: urinary excretion of soluble adhesion molecules and of the complement-split product C4d. Nephron Clin Pract, 2003; 94: cl9-26
6. Li B, Hartono C, Ding R et al: Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perform and granzyme B in urine. N Engl J Med, 2001; 344: 947-54
7. Muthukumar T, Dadhania D, Ding R et al: Messenger RNA for FOXP3 in die urine of renal-allograft recipients. N Engl J Med, 2005; 353: 2342-51
8. Gupta RK, Jain M, Sharma RK: Serum & urinary interleukin-2 levels as predictors in acute renal allograft rejection. Indian J Med Res, 2004; 119: 24-27
9. Kirschfink M, Wienert T, EB AP et al: [The effect of the complement system on the acute reversible rejection of kidney transplants]. Immun Infekt, 1995; 23: 55-56
10. van Son WJ, van der Woude FJ, van der Hem GK et al: Complement activation associated with active cytomegalovirus infection in renal transplant patients, and its absence in transplant rejection episodes. Transplantation, 1985; 39: 510-14
11. Nickeleit V, Zeiler M, Gudat F et al: Detection of the complement degradation product C4d in renal allografts: diagnostic and therapeutic implications. J Am Soc Nephrol, 2002; 13: 242-51
12. Pratt JR, Basheer SA, Sacks SH: Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med, 2002; 8: 582-87
13. Torrealba JR, Samaniego M, Pascual J et al: C4d-positive interacinar capillaries correlates with donor-specific antibody-mediated rejection in pancreas allografts. Transplantation, 2008; 86:1849-56
14. Tang S, Zhou W, Sheerin NS et al: Contribution of renal secreted complement C3 to the circulating pool in humans. J Immunol, 1999; 162: 4336-41
15. Weiner SM, Thiel J, Berg T et al: Impact of in vivo complement activation and cryoglobulins on graft outcome of HCV-infected renal allograft recipients. Clin Transplant, 2004; 18: 7-13
16. Rother E, Lang B, Coldewey R et al: Complement split product C3d as an indicator of disease activity in systemic lupus erythematosus. Clin Rheumatol, 1993; 12: 31-35
17. Vallhonrat H, Williams WW, Dec GW et al: Complement activation products in plasma after heart transplantation in humans. Transplantation, 2001;71:1308-11
18. Divate SA: Acute renal allograft rejection: progress in understanding cellular and molecular mechanisms. J Postgrad Med, 2000; 46: 293-96
19. de Vries B, Walter SJ, Peutz-Kootstra CJ et al: The mannose-binding lectin-pathway is involved in complement activation in the course of renal ischemia-reperfusion injury. Am J Pathol, 2004; 165:1677-88
20. Delis S, Dervenis C, Bramis J et al: Vascular complications of pancreas transplantation. Pancreas, 2004; 28: 413-20
21. Del Conde I, Cruz MA, Zhang H et al: Platelet activation leads to activation and propagation of die complement system. J Exp Med, 2005; 201:871-79
22. Nikolaidis P, Amin RS, Hwang CM et al: Role of sonography in pancreatic transplantation. Radiographics, 2003; 23: 939-49